Published in Eur J Immunol on May 01, 1978
Ontogeny of murine macrophages: functions related to antigen presentation. Infect Immun (1982) 0.98
Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome. J Exp Med (1993) 0.86
No evidence of abnormal regulation of antibody response to coxsackievirus B4 antigen in prediabetic children. Clin Exp Immunol (2001) 0.77
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature (1995) 7.52
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet (2001) 2.79
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J (1996) 2.68
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27
Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24
Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24
Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology (1968) 2.20
Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized. J Exp Med (1966) 2.16
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J Exp Med (1966) 1.94
Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med (1967) 1.89
Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89
Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J Exp Med (1974) 1.86
Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits. J Immunol (1968) 1.82
A study of the 'termination' of tolerance to BSA with DNP-BSA in rabbits: relative affinities of the antibodies for the immunizing and the paralysing antigens. Immunology (1967) 1.82
The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene (2000) 1.66
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XI. Pseudogenetic restrictions of hybridoma suppressor factors. J Exp Med (1981) 1.46
Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1972) 1.39
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. IX. Characterization of Idiotype-specific effector-phase suppressor cells on plaque-forming cell responses in vitro. J Exp Med (1981) 1.31
Studies on antigenic competition. J Exp Med (1969) 1.26
Effect of tolerance and immunity on antibody affinity. Transplant Rev (1972) 1.25
The effect of dose in tolerance induction on the subsequent response to a cross-reactive antigen. Immunology (1969) 1.23
Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse. Clin Exp Immunol (1974) 1.22
Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide. Clin Exp Immunol (1969) 1.22
Ontogeny of B-lymphocyte function. II. Ability of endotoxin to increase the heterogeneity of affinity of the immune response of B lymphocytes from fetal mice. J Exp Med (1976) 1.18
Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol (1972) 1.18
Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol Cell Biol (1996) 1.15
Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem (2001) 1.14
Impairment of host-versus-graft reaction in pregnant mice. II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy. Cell Immunol (1980) 1.11
Studies on the control of antibody synthesis. XII. Genetic influences on antibody affinity. Immunology (1978) 1.10
The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis. Transfusion (1968) 1.10
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VII. Idiotype-specific suppression of plaque-forming cell responses. J Exp Med (1981) 1.09
Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc Natl Acad Sci U S A (1980) 1.09
Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med (1977) 1.06
T cells with receptors for IgD. Nature (1985) 1.05
Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. III. Absence in nu/nu mice: evidence for T-cell dependence of the anti-idiotypic-antibody response. J Exp Med (1979) 1.05
Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res Treat (2000) 1.04
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes. J Immunol (1981) 1.04
The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology (2000) 1.04
Studies on the control of antibody synthesis. V. Effect of nonspecific modification of the magnitude of the immune response on the affinity of the antibody synthesized. J Immunol (1974) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J Immunol Methods (1992) 1.01
Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations. J Exp Med (1985) 1.01
Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00
A comparison of the Farr technique with equilibrium dialysis for measurement of antibody concentration and affinity. J Immunol Methods (1975) 0.99
An idiotype-specific helper population that bears immunoglobulin, Ia, and Lyt-1 determinants. J Exp Med (1984) 0.99
Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol (1988) 0.99
Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation. Nature (1980) 0.98
Determination of antibody avidity at the cellular level by the plaque inhibition technique: effect of valence of the inhibitor. J Immunol Methods (1975) 0.97
Ontogeny of B-lymphocyte function. V. Thymus cell involvement in the functional maturation of B-lymphocytes from fetal mice transferred into adult irradiated hosts. J Exp Med (1978) 0.97
Effect of variation in antibody-hapten association constant upon the biologic activity of the antibody. J Immunol (1965) 0.97
Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses. J Exp Med (1983) 0.96
Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies. J Exp Med (1981) 0.96
Cellular control of IgE induction by a polyphenol-rich compound. Preferential activation of Th2 cells. J Immunol (1990) 0.96
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XII. Fine specificity of anti-idiotypic suppressor T cells (Ts2). J Exp Med (1981) 0.96
The anamnestic antibody response to type 3 specific pneumococcal polysaccharide. J Exp Med (1969) 0.96
Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice. J Immunol (1980) 0.95
A cultured malignant B-1 line serves as a model for Richter's syndrome. J Immunol (1994) 0.95
Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol (1972) 0.95
Changes in affinity of 19 and 7S antibodies at the cellular level in responses to hapten conjugates of varying T dependency. Cell Immunol (1978) 0.95
Lymphocyte transformation induced by autologous cells: XVIII. Impaired autologous mixed lymphocyte reaction in subjects with AIDS-related complex. Clin Exp Immunol (1987) 0.95
Age-related strain differences in the development of auto-anti-idiotypic antibody regulation in the splenic and mucosal-associated lymphoid systems. Gerontology (1985) 0.95
Heterogeneity of nonspecific forces in the precipitation reaction. J Immunol (1966) 0.95
Studies on antigenic competition. 3. Effect on antigenic competition on antibody affinity. Immunology (1974) 0.94
Tolerance induced by TNP-derivatized syngeneic erythrocytes: evidence for cooperation between hapten-specific T and hapten-specific B lymphocytes in the immune response. J Immunol (1978) 0.94
Ly-1 B helper cells in autoimmune "viable motheaten" mice. J Immunol (1987) 0.94
Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Soc Exp Biol Med (1981) 0.93
Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system. Adv Immunol (1984) 0.93
Production of auto-antiidiotypic antibody during the normal immune response. VII. Analysis of the cellular basis for the increased auto-antiidiotype antibody production by aged mice. J Exp Med (1983) 0.93
Characterization of anti-idiotypic suppressor T cells (Tsid) induced after antigen priming. J Immunol (1984) 0.93
Degeneracy of antibody specificity. J Immunol (1983) 0.92
Studies on antigenic competition. Efforts to identify the cellular basis of competition using a cell transfer system. Cell Immunol (1974) 0.92
Studies on the control of antibody synthesis. XIV. Role of T cells in regulating antibody affinity. Cell Immunol (1979) 0.92
Immune suppression in vivo with antigen-modified syngeneic cells. III. Distinctions between T cell tolerance and T cell mediated suppression. J Immunol (1979) 0.92
Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis. Cell Immunol (1988) 0.91
Role of IgD and T delta cells in the regulation of the humoral immune response. Immunol Rev (1988) 0.91
Immune suppression in vivo with antigen-modified syngeneic cells. V. Interacting T cell subpopulations in the suppressor pathway. J Immunol (1980) 0.91
The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritis. J Immunol (1988) 0.91
Hapten specificity of cellular immune responses as compared with the specificity of serum anti-hapten antibody. Immunology (1970) 0.91
The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis. Toxicol Appl Pharmacol (1999) 0.90
Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol Appl Pharmacol (1992) 0.90
Studies on the mechanism of the suppression of active antibody synthesis by passively administered antibody. J Immunol (1969) 0.90
Enthalpy-entropy compensation in dinitrophenyl--anti-dinitrophenyl antibody interaction(s). Immunology (1977) 0.90
Effect of tolerance and of antibody mediated immune suppression on the avidity of the cellular and humoral immune response. Cell Immunol (1973) 0.90
Physiology of IgD. V. Enhancement of antibody responses in vivo by allo anti-IgD is due primarily to an indirect effect on B cells. J Immunol (1985) 0.90